[
    [
        {
            "time": "",
            "original_text": "益方生物第三代EGFR抑制剂BPI-D0316项目与贝达药业授权合作",
            "features": {
                "keywords": [
                    "益方生物",
                    "第三代EGFR抑制剂",
                    "BPI-D0316",
                    "贝达药业",
                    "授权合作"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "益方生物第三代EGFR抑制剂BPI-D0316项目与贝达药业授权合作",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "创新药企益方生物“自研+合作”模式加速发展",
            "features": {
                "keywords": [
                    "创新药企",
                    "益方生物",
                    "自研+合作",
                    "加速发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "创新药企益方生物“自研+合作”模式加速发展",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]